Apply a Physiologically Based Pharmacokinetic Model to Promote the Development of Enrofloxacin Granules: Predict Withdrawal Interval and Toxicity Dose

Abstract

Enrofloxacin (ENR) granules were developed to prevent and control the infections caused by foodborne zoonotic intestinal pathogens in our previous studies. To promote the further development of ENR granules and standardize their usage in pigs, a physiologically based pharmacokinetic (PBPK) model of the ENR granule in pigs was built to determine the withdrawal time (WT) and evaluate the toxicity to pigs. Meanwhile, the population WT was determined by a Monte Carlo analysis to guarantee pork safety. The fitting results of the model showed that the tissue residual concentrations of ENR, ciprofloxacin, and ENR plus ciprofloxacin were all well predicted by the built PBPK model (R2 > 0.82). When comparing with the EMA’s WT1.4 software method, the final WT (6 d) of the ENR granules in the population of pigs was well predicted. Moreover, by combining the cytotoxicity concentration (225.9 µg/mL) of ENR against pig hepatocytes, the orally safe dosage range (≤130 mg/kg b.w.) of the ENR granules to pigs was calculated based on the validated PBPK model. The well-predicted WTs and a few uses in animals proved that the PBPK model is a potential tool for promoting the judicious use of antimicrobial agents and evaluating the toxicity of the veterinary antimicrobial products.

A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against Streptococcus suis

“…A physiologically based pharmacokinetic (PBPK) model is characterized by anatomical and biochemical factors, which is a mechanistic approach to simulate the absorption, distribution, metabolism, and elimination of chemicals in the body. It has been applied for dose optimization ( Zhou et al, 2021 ; Mi et al, 2022 ), food safety assessment of animal-derived food products ( Lin et al, 2016 ; Henri et al, 2017 ), and chemical risk assessment ( Chou and Lin, 2019 ). The semi-mechanistic PD model can quantify resistance development and bacterial regrowth under drug exposure.…”

Enrofloxacin, Effective Treatment of Pseudomonas aeruginosa and Enterococcus faecalis Infection in Oreochromis niloticus

“…Enrofloxacin is a synthetic antibacterial drug related to fluoroquinolones and remains extensively used in veterinary medicine [18]. Enrofloxacin acts by inhibiting the DNA gyrase enzyme (topoisomerase II); DNA gyrase is responsible for the standard coiling of DNA within the nucleus [19].…”

A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs

“…By integrating microdialysis, a PBPK model is capable of predicting the drug concentration in the lung interstitial fluid. The PK/pharmacodynamic (PD) parameters of lung interstitial fluid in virtual individuals are determined by comparison with target values, allowing the dosage to be optimized [ 11 , 12 ]. The probability of target attainment (PTA) is the percentage of individuals reaching the target PK/PD parameters at different bacterial minimum inhibitory concentrations (MICs).…”